Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 449

    1.

    New insights into the protein C pathway: potential implications for the biological activities of drotrecogin alfa (activated).

    Macias WL, Yan SB, Williams MD, Um SL, Sandusky GE, Ballard DW, Planquois JM.

    Crit Care. 2005;9 Suppl 4:S38-45. Epub 2005 Aug 25. Review.PMID: 16168074 [PubMed - indexed for MEDLINE]Related articles

    2.

    Endogenous protein C activation in patients with severe sepsis.

    Liaw PC.

    Crit Care Med. 2004 May;32(5 Suppl):S214-8. Review.PMID: 15118520 [PubMed - indexed for MEDLINE]Related articles

    3.

    Benefit-risk assessment of drotrecogin alfa (activated) in the treatment of sepsis.

    De Backer D.

    Drug Saf. 2007;30(11):995-1010. Review.PMID: 17973539 [PubMed - indexed for MEDLINE]Related articles

    4.

    Activated protein C versus protein C in severe sepsis.

    Yan SB, Dhainaut JF.

    Crit Care Med. 2001 Jul;29(7 Suppl):S69-74. Review.PMID: 11445737 [PubMed - indexed for MEDLINE]Related articles

    5.

    Inflammation, sepsis, and coagulation.

    Esmon CT, Fukudome K, Mather T, Bode W, Regan LM, Stearns-Kurosawa DJ, Kurosawa S.

    Haematologica. 1999 Mar;84(3):254-9. Review.PMID: 10189392 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Activated protein C and sepsis.

    O'Brien LA, Gupta A, Grinnell BW.

    Front Biosci. 2006 Jan 1;11:676-98. Review.PMID: 16146761 [PubMed - indexed for MEDLINE]Related articles

    7.

    Soluble thrombomodulin, plasma-derived unactivated protein C, and recombinant human activated protein C in sepsis.

    Dhainaut JF, Yan SB, Cariou A, Mira JP.

    Crit Care Med. 2002 May;30(5 Suppl):S318-24. Review.PMID: 12004254 [PubMed - indexed for MEDLINE]Related articles

    8.

    Leukocyte and endothelial cell interactions in sepsis: relevance of the protein C pathway.

    Joyce DE, Nelson DR, Grinnell BW.

    Crit Care Med. 2004 May;32(5 Suppl):S280-6. Review.PMID: 15118531 [PubMed - indexed for MEDLINE]Related articles

    9.

    Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation.

    Finigan JH, Dudek SM, Singleton PA, Chiang ET, Jacobson JR, Camp SM, Ye SQ, Garcia JG.

    J Biol Chem. 2005 Apr 29;280(17):17286-93. Epub 2005 Feb 14.PMID: 15710622 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    The protein C pathway.

    Esmon CT.

    Chest. 2003 Sep;124(3 Suppl):26S-32S. Review.PMID: 12970121 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Drotrecogin alfa (activated) (recombinant human activated protein C) reduces host coagulopathy response in patients with severe sepsis.

    Dhainaut JF, Yan SB, Margolis BD, Lorente JA, Russell JA, Freebairn RC, Spapen HD, Riess H, Basson B, Johnson G 3rd, Kinasewitz GT; PROWESS Sepsis Study Group.

    Thromb Haemost. 2003 Oct;90(4):642-53.PMID: 14515185 [PubMed - indexed for MEDLINE]Related articles

    13.

    [The numerous properties of the anticoagulant protein C]

    Cerchiara E, Tirindelli MC, Giannetti B, Dicuonzo G, Avvisati G.

    Clin Ter. 2007 Mar-Apr;158(2):181-7. Review. Italian. PMID: 17566522 [PubMed - indexed for MEDLINE]Related articles

    14.

    Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation.

    Van de Wouwer M, Collen D, Conway EM.

    Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):1374-83. Epub 2004 Jun 3. Review.PMID: 15178554 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Activated protein C alters cytosolic calcium flux in human brain endothelium via binding to endothelial protein C receptor and activation of protease activated receptor-1.

    Dömötör E, Benzakour O, Griffin JH, Yule D, Fukudome K, Zlokovic BV.

    Blood. 2003 Jun 15;101(12):4797-801. Epub 2003 Feb 13.PMID: 12586611 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Anti-inflammatory effect of activated protein C in gastric epithelial cells.

    Nakamura M, Gabazza EC, Imoto I, Yano Y, Taguchi O, Horiki N, Fukudome K, Suzuki K, Adachi Y.

    J Thromb Haemost. 2005 Dec;3(12):2721-9. Epub 2005 Oct 25.PMID: 16246255 [PubMed - indexed for MEDLINE]Related articles

    17.

    Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells.

    Bae JS, Yang L, Rezaie AR.

    Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2867-72. Epub 2007 Feb 13.PMID: 17299037 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis.

    Barton P, Kalil AC, Nadel S, Goldstein B, Okhuysen-Cawley R, Brilli RJ, Takano JS, Martin LD, Quint P, Yeh TS, Dalton HJ, Gessouron MR, Brown KE, Betts H, Levin M, Macias WL, Small DS, Wyss VL, Bates BM, Utterback BG, Giroir BP.

    Pediatrics. 2004 Jan;113(1 Pt 1):7-17.PMID: 14702440 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Prevention of endothelial cell injury by activated protein C: the molecular mechanism(s) and therapeutic implications.

    Okajima K.

    Curr Vasc Pharmacol. 2004 Apr;2(2):125-33. Review.PMID: 15320513 [PubMed - indexed for MEDLINE]Related articles

    20.

    The cytoprotective protein C pathway.

    Mosnier LO, Zlokovic BV, Griffin JH.

    Blood. 2007 Apr 15;109(8):3161-72. Epub 2006 Nov 16. Review.PMID: 17110453 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data